GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
NASDAQ:ADMS
Delisted

Adamas Pharmaceuticals Stock Price (Quote)

$8.22
+0 (+0%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $8.22 $8.22 Friday, 27th May 2022 ADMS stock ended at $8.22. During the day the stock fluctuated 0% from a day low at $8.22 to a day high of $8.22.
90 days $8.22 $8.22
52 weeks $4.02 $8.25

Historical Adamas Pharmaceuticals prices

Date Open High Low Close Volume
2019-09-24 $7.48 $7.60 $7.19 $7.30 996 172
2019-09-23 $7.22 $7.78 $7.20 $7.46 1 060 221
2019-09-20 $6.74 $7.41 $6.74 $7.33 1 426 203
2019-09-19 $6.65 $7.16 $6.50 $6.75 1 461 589
2019-09-18 $6.30 $6.71 $6.25 $6.64 1 030 672
2019-09-17 $6.26 $6.48 $6.20 $6.30 1 145 401
2019-09-16 $6.33 $6.53 $6.19 $6.25 900 777
2019-09-13 $6.30 $6.48 $6.00 $6.33 1 285 071
2019-09-12 $6.08 $6.28 $5.84 $6.24 430 457
2019-09-11 $5.74 $6.15 $5.74 $6.08 274 409
2019-09-10 $5.57 $5.76 $5.43 $5.72 210 721
2019-09-09 $5.82 $5.94 $5.51 $5.58 325 782
2019-09-06 $5.97 $6.09 $5.83 $5.85 284 355
2019-09-05 $6.04 $6.14 $5.87 $5.97 203 001
2019-09-04 $6.03 $6.12 $5.80 $5.95 251 941
2019-09-03 $6.24 $6.54 $5.98 $6.00 603 522
2019-08-30 $6.31 $6.65 $6.25 $6.31 1 846 923
2019-08-29 $6.01 $6.36 $6.00 $6.30 214 768
2019-08-28 $5.92 $6.08 $5.85 $5.96 138 486
2019-08-27 $6.08 $6.11 $5.80 $5.92 215 499
2019-08-26 $6.13 $6.23 $5.95 $6.03 210 574
2019-08-23 $6.15 $6.38 $6.02 $6.06 232 211
2019-08-22 $6.21 $6.42 $6.02 $6.13 180 292
2019-08-21 $6.23 $6.38 $6.11 $6.14 162 398
2019-08-20 $6.23 $6.37 $6.10 $6.18 132 100
Click to get the best stock tips daily for free!

About Adamas Pharmaceuticals

Adamas Pharmaceuticals Adamas Pharmaceuticals, Inc., a pharmaceutical company, focuses on the development and commercialization of therapeutics targeting chronic disorders of the central nervous systems. The company’s lead product candidate is the ADS-5102 that is in Phase 3 clinical development for the treatment of levodopa-induced dyskinesia, a movement disorder associated with Parkinson’s disease; and in a Phase 2 clinical study for the treatment of symptoms assoc... ADMS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT